http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103027895-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1e96f9c1e753727fc5529a6b974143b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
filingDate 2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4309cb3ee1c63f56ad6c052d3e4d910
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd0b5fdd3b82835e770a790219c9625e
publicationDate 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103027895-B
titleOfInvention Sugar-free cilnidipine dry-blend suspension and preparation method thereof
abstract The invention relates to the technical field of medicine, belongs to a chemical medicine for treating human diseases and a preparation method thereof, and particularly relates to a sugar-free cilnidipine dry-blend suspension and a preparation method thereof. The sugar-free cilnidipine dry-blend suspension is prepared from the following components in percentage by weight: 10% of cilnidipine, 20% of hydroxypropyl cellulose sodium, 25% of xanthan gum, 15% of sodium lauryl sulfate and 30% of fruit-flavor essence. The preparation method comprises the following steps: respectively drying and pulverizing cilnidipine, hydroxypropyl cellulose sodium, xanthan gum, sodium lauryl sulfate and fruit-flavor essence, and passing through an 80-mesh screen; evenly mixing the dried and pulverized medicinal powder by an equivalent incremental method, detecting an intermediate, packaging, carrying out complete inspection, and warehousing to obtain the sugar-free cilnidipine dry-blend suspension. The sugar-free cilnidipine dry-blend suspension is convenient to take, has high bioavailability, fully displays the function of cilnidipine on treating hypertension, and can be taken by diabetics.
priorityDate 2011-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DQU4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452041512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448380735
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282138
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85165
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86643
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4615
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692753
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591612
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC9X4J0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP30424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08318

Total number of triples: 39.